New hope for advanced uterine cancer: drug trial targets tough cases
Disease control
Not yet recruiting
This study tests a drug called enfortumab vedotin in up to 12 people with advanced endometrial (uterine) cancer that has worsened after previous treatments, including immunotherapy. The goal is to see if the drug can shrink tumors and how safe it is. Participants receive treatmen…
Phase: PHASE2 • Sponsor: William Bradley • Aim: Disease control
Last updated May 17, 2026 13:52 UTC